In short. The injection risks shared with any injectable, the material-specific questions of allergy and granuloma, unknown long-term behaviour, and the options beside it.
Key points
- A material that is broken down and cleared is presented as inherently safer, and that is a reasoned argument rather than a dataset.
- The argument may turn out to be right.
- Nobody has followed treated people for long enough to show that it is.
The risks of this product class divide into those shared with every injectable and those that follow from what the material is. Both belong in the same conversation, because a person deciding about a course of treatment is deciding about the whole list rather than the part that is easiest to describe.
The shared risks
An injection into the skin can bruise, swell and be tender for a few days, and there is a small risk of infection at the site. Rarely, material placed in the face can enter or obstruct a blood vessel, which is a serious event that needs immediate recognition and treatment, and it is the reason these injections belong with a clinician who can recognise one. Those risks are not specific to polynucleotides, and they are not reduced by the material being biological.
The risks specific to the material
Three follow from what the material is. It is derived from a marine source, so an allergy question exists and no straightforward test predicts a reaction. It is intended to provoke a response in the tissue, so nodules and granulomas are recognised for materials of this kind, and such a reaction is harder to deal with than an unwanted filler, which can at least be dissolved. And its behaviour over years is not known, because the class has not been in aesthetic use long enough for a long-term cohort to exist, so the honest description of long-term safety is that it is unmeasured rather than reassuring.
Unknown is a real answer about long-term safety
A material that is broken down and cleared is presented as inherently safer, and that is a reasoned argument rather than a dataset. The argument may turn out to be right. Nobody has followed treated people for long enough to show that it is.
The alternatives, stated with their limits
Doing nothing is a genuine option, and the appearance a person wants to change often changes on its own. A prescription topical retinoid with consistent sun protection is the best-evidenced thing available for skin texture and costs a fraction of a course of injections. Where the goal is volume, a hyaluronic acid filler occupies a space, has a long published record and can be dissolved if the result is wrong. The collagen-stimulating injectables have larger and longer published follow-up, and carry their own risks. Where an under-eye shadow is cast by a fat pad, none of these addresses it, and an operation is the honest answer.
Have these assessed by a clinician
- A firm lump, nodule or area of swelling that appears weeks or months after an injection.
- Skin that turns white, dusky or painful during or shortly after an injection, or any change in vision.
- Spreading redness, warmth, fever, or pain that is worsening rather than settling.
Nothing on this page is a recommendation for or against any of these options.
Frequently asked questions
What are the risks specific to a polynucleotide injectable?
Three follow from the material: an allergy question, since it is marine-derived and no straightforward test predicts a reaction; the possibility of nodules or a granuloma, which is recognised for materials intended to provoke a tissue response and is harder to deal with than an unwanted filler; and long-term behaviour that is simply not known.
Is there anything better studied to compare it with?
Several things, depending on the goal. For skin texture, a prescription topical retinoid with sun protection is the best-evidenced option. For volume, a hyaluronic acid filler has a long published record and can be dissolved. The collagen-stimulating injectables have larger and longer published follow-up, and their own risks.
What should I do if a lump appears months after an injection?
Have it assessed by a clinician rather than watching it. A firm lump or nodule appearing weeks or months afterwards, spreading redness with fever, or pain that is worsening rather than settling are all reasons to contact the service that treated you or the hospital’s outpatient channels.
Risks & Limitations
- The published studies behind this product class are small, short and concentrated in a few centres, and a substantial share are supported by the companies selling the material.
- Long-term behaviour of the material is unmeasured, which is not the same as established and not the same as disproven.
- The material is marine-derived, so an allergy question exists and no straightforward test predicts a reaction.
- A material intended to provoke a tissue response can produce nodules or a granuloma, which are harder to manage than an unwanted filler that can be dissolved.
- A device registration records the safety and performance of a material and is not a finding that the treatment works; an injectable into the face also carries the rare risk of a vascular event.
When to Seek Care
- A firm lump, nodule or area of swelling appearing weeks or months after an injection — have it assessed by a clinician.
- Skin that turns white, dusky or painful during or shortly after an injection, or any change in vision — seek care immediately.
- Spreading redness, warmth or fever, or pain that is worsening rather than settling.
- Contact the service that holds your records, or the hospital’s outpatient channels, rather than relying on a website.
References & Further Reading
- European Medicines Agency (EMA) and national regulators — classification of injectable products and published assessment reports
- U.S. Food and Drug Administration (FDA) — device and drug classification, and approved labelling
- National Medical Products Administration (NMPA, China) — registration of medical devices and medicines
- Cochrane Library — systematic reviews
- Chinese Medical Association Plastic Surgery Branch — clinical guidance
This page is patient education, not medical advice, and it does not cite individual studies. It reviews evidence and regulation; it is not a booking page and does not recommend a treatment. Discuss your own case with a qualified clinician. To ask a question about this review, see Contact & Consultation.